Literature DB >> 25229390

Synthesis of a 3-(α-styryl)benzo[b]-thiophene library via bromocyclization of alkynes and palladium-catalyzed to sylhydrazones cross-couplings: evaluation as antitubulin agents.

Bret Tréguier1, Marie Lawson, Guillaume Bernadat, Jérôme Bignon, Joëlle Dubois, Jean-Daniel Brion, Mouad Alami, Abdallah Hamze.   

Abstract

A library of functionalized 3-(α-styryl)-benzo[b]thiophenes, endowed with a high level of molecular diversity, was efficiently synthesized by applying a synthetic sequence that allowed introduction of various substituents on aromatic A, B, and C-rings. The strategy developed involves the synthesis of 3-bromobenzo[b]thiophene derivatives through a bromocyclization step of methylthio-containing alkynes using N-methylpyrrolidin-2-one hydrotribromide reagent (MPHT). Further coupling of 3-bromobenzothiophenes under palladium-catalysis with N-tosylhydrazones efficiently furnished 2-aryl-3-(α-styryl)benzo[b]thiophene derivatives. The antiproliferative properties of target compounds were studied. Among them, compound 5m has demonstrated submicromolar cytotoxic activity against HCT-116 cell line, and inhibited the polymerization of tubulin at micromolar level comparable to that of CA-4.

Entities:  

Keywords:  N-tosylhydrazone; antimitotic agents; bromocyclization; migratory insertion; palladium; α-styrylbenzo[b]thiophene

Mesh:

Substances:

Year:  2014        PMID: 25229390     DOI: 10.1021/co500115b

Source DB:  PubMed          Journal:  ACS Comb Sci        ISSN: 2156-8944            Impact factor:   3.784


  2 in total

Review 1.  Malononitrile dimer as a privileged reactant in design and skeletal diverse synthesis of heterocyclic motifs.

Authors:  Ahmad Shaabani; Seyyed Emad Hooshmand
Journal:  Mol Divers       Date:  2018-01-03       Impact factor: 2.943

2.  Ru(ii)-catalyzed C6-selective C-H acylmethylation of pyridones using sulfoxonium ylides as carbene precursors.

Authors:  Yangjie Fu; Zhaohui Wang; Qiyu Zhang; Zhiyu Li; Hong Liu; Xiaoling Bi; Jiang Wang
Journal:  RSC Adv       Date:  2020-02-11       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.